| Description | Human adipocytes (HPAd) provide an ideal cell model and facilitate life science research and drug discovery for obesity, diabetes and cardiovascular diseases. We extract HPAd from human subcutaneous and cardiac adipose tissue, and cryopreserve these fibroblast-like precursor cells at the end of the Human adipocytes (HPAd) provide an ideal cell model and facilitate life science research and drug discovery for obesity, diabetes and cardiovascular diseases. We extract HPAd from human subcutaneous and cardiac adipose tissue, and cryopreserve these fibroblast-like precursor cells at the end of the primary culture. They can be transmitted for two passages before differentiating into human adipocytes (HAd). Complete differentiation can be easily achieved by using pre-adipocyte differentiation medium. It is expected that mature HAd should remain healthy 10 days after differentiation induction and should respond within at least 2 weeks after full differentiation. The fat mass can be controlled by inhibiting the differentiation of HPAd and increasing the lipolysis effect. HPAd can also be pre-screened to express adipocyte markers.... Read More | Creative Biolabs offers a range of recombinant cell lines for Immunotherapy discovery and development. | This product is a Mouse Gm11437 membrane protein expressed in vitro E.coli expression system. The protein is for research use only and is not approved for use in humans or in clinical diagnosis. | Recombinant Norovirus GI.1 Virus-like Particles (NoV GI.1 VLPs) are produced in Baculovirus/Insect cell expression system, assembled with VP1 structure protein. VLP is mimicking the native 3D structure of viruses which can elicit strong immune responses. However, VLPs lack viral genomic material Recombinant Norovirus GI.1 Virus-like Particles (NoV GI.1 VLPs) are produced in Baculovirus/Insect cell expression system, assembled with VP1 structure protein. VLP is mimicking the native 3D structure of viruses which can elicit strong immune responses. However, VLPs lack viral genomic material which makes them non-infectious, unable to replicate and enhance the safety during manufacture and administration. NoV GI.1 VLPs can be used in the development of NoV GI.1 diagnostics and in vaccine development and R&D (including use as an immunogen).... Read More | Recombinant O'nyong'nyong Virus-like Particles (ONNV VLPs) are produced in mammalian HEK293 human cells, assembled with E1, E2 and Capsid proteins. VLP is mimicking the native 3D structure of viruses which can elicit strong immune responses. However, VLPs lack viral genomic material which makes themRecombinant O'nyong'nyong Virus-like Particles (ONNV VLPs) are produced in mammalian HEK293 human cells, assembled with E1, E2 and Capsid proteins. VLP is mimicking the native 3D structure of viruses which can elicit strong immune responses. However, VLPs lack viral genomic material which makes them non-infectious, unable to replicate and enhance the safety during manufacture and administration. ONNV VLPs can be used in the development of ONNV diagnostics and in vaccine development and R&D (including use as an immunogen).... Read More |